Get the Stockscreener App
0.00
100.00%
-11.80
After Hours:
12.00
12.00
+
Ekso Bionics Holdings Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
See More
Previous Close:
$11.80
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$42.05M
Revenue:
$11.57M
Net Income/Loss:
$-16.07M
P/E Ratio:
0.00
EPS:
-5.3918
Net Cash Flow:
$-12.14M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$13.50
Ekso Bionics Holdings Inc Stock (EKSO) Company Profile
Name
Ekso Bionics Holdings Inc
Sector
Industry
Phone
510-984-1761
Address
101 GLACIER POINT, SAN RAFAEL
Compare EKSO vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EKSO
Ekso Bionics Holdings Inc
|
0.00 | 42.05M | 11.57M | -16.07M | -12.14M | -5.3918 |
ISRG
Intuitive Surgical Inc
|
402.95 | 144.07B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
140.71 | 39.67B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.18 | 31.54B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.71 | 30.39B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
188.45 | 27.36B | 5.54B | 1.52B | 1.74B | 10.37 |
Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-16 | Initiated | SunTrust | Buy |
Ekso Bionics Holdings Inc Stock (EKSO) Latest News
Ekso Bionics Holdings Inc (EKSO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ekso Bionics Holdings Inc (EKSO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ekso Bionics Holdings Inc (EKSO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ekso Bionics Holdings Inc (EKSO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ekso Bionics (EKSO) Holds Gains as Stock Tests Near-Term Resistance LevelsIchimoku Cloud - newsline.com
Ekso Bionics Holdings Stock (US2826641040): Ticker Change To ChronoScale Raises Questions For Legacy - AD HOC NEWS
Ekso Bionics (EKSO) Shows Modest Gains as Shares Approach Resistance LevelStock Buy Zone - newsline.com
Chronoscale To Divest Ekso Bionics And Focus On Cloud Business - TradingView
ChronoScale (NASDAQ: CHRN) plans Ekso divestiture to become cloud-focused - Stock Titan
Industrial Exoskeletons Market Is Going to Boom |• Ekso Bionics • SuitX • Sarcos Robotics - openPR.com
ChronoScale Corporation: Shareholders Board Members Managers and Company Profile | US1709241046 - marketscreener.com
Ekso Bionics (EKSO) Climbs 1.29% as Stock Tests Key Resistance LevelTechnical Analysis Picks - The Legal Advocate
Ekso Bionics (EKSO) Gains Ground as Shares Approach Key ResistanceFactor Timing - The Legal Advocate
CHRN - Finviz
Ekso Bionics (EKSO) Moves Higher as Stock Tests Resistance Near $12.39Zero Lag EMA - The Legal Advocate
ChronoScale Corporation (formerly Ekso Bionics) Files 8-K/A Amendment Detailing Phantom PSU Awards for Executives - Minichart
ChronoScale (CHRN) shifts executive phantom PSU payouts to stock and cash - Stock Titan
ChronoScale Corp (CHRN) director awarded 200,000 restricted shares vesting over two years - Stock Titan
ChronoScale (CHRN) director Wes Cummins granted 200,000 restricted shares in equity award - Stock Titan
[Form 4] EKSO BIONICS HOLDINGS, INC. Insider Trading Activity - Stock Titan
Richard Nottenburg awarded 200K ChronoScale (CHRN) restricted shares - Stock Titan
ChronoScale (CHRN) director awarded 200,000 restricted shares vesting over two years - Stock Titan
ChronoScale (CHRN) director receives 109,357-share equity grant in Form 4 filing - Stock Titan
Sports Exoskeleton Market to Reach USD 1,543.98 Million by 2033 - openPR.com
Ekso Bionics Holdings stock (US2826641040): Q1 2026 results and exoskeleton strategy in focus - AD HOC NEWS
ChronoScale (CHRN) director Richard Nottenburg files Form 3 with no trades - Stock Titan
ChronoScale Corp (CHRN) director reports 3.56M shares tied to incentive plan units - Stock Titan
Armistice Capital (CHRN) reports 187,151 shares, 4.99% ownership - Stock Titan
ChronoScale (CHRN) CEO and director file initial insider ownership - Stock Titan
CHRN SEC FilingsChronoScale Corp 10-K, 10-Q, 8-K Forms - Stock Titan
EKSO SEC FilingsEkso Bionics 10-K, 10-Q, 8-K Forms - Stock Titan
Ekso Bionics Holdings stock (US2826641040): Pioneering exoskeleton tech for medical and industrial u - AD HOC NEWS
Mink Brook amendment shows 0 CHRN shares held by related entities (CHRN) - Stock Titan
Walk Assist Robot Market Research Report 2026-2031: Leading firms Such as Ekso Bionics, Lifeward, Cyberdyne, Ottobock, and DIH Medical Lead the $568.81 Million Market - Yahoo Finance
TradingKey - TradingKey
Applied Digital gains control of ChronoScale (NASDAQ: EKSO) with 97.5% stake - Stock Titan
Exoskeleton News, May 2026 – Week 19 – Numerous new events and much more… - Exoskeleton Report
Applied Digital Just Spun Out ChronoScale: What CHRN Means for APLD Stock Now - TechStock²
ChronoScale names Cenly Chen CEO to drive AI compute expansion - MSN
CHRN Should I Buy - Intellectia AI
Ekso Bionics Holdings: Fundamental Analysis and Financial Ratings | EKSO | US2826444000 - marketscreener.com
ChronoScale Corporation Common Stock (CHRN) 10K Form and Latest SEC Filings 2026 - MarketBeat
ChronoScale Corporation Common Stock (CHRN) Insider Trading Activity 2026 - MarketBeat
ChronoScale Corporation Common Stock (CHRN) Stock Price, News & Analysis - MarketBeat
CHRN PE Ratio & Valuation, Is CHRN Overvalued - Intellectia AI
ChronoScale Names Cenly Chen CEO to Lead Expansion of AI Compute Infrastructure - citybiz
CHRN Technical Analysis & Stock Price Forecast - Intellectia AI
ChronoScale names Cenly Chen as chief executive officer By Investing.com - Investing.com South Africa
ChronoScale names Cenly Chen as chief executive officer - Investing.com
ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth - The Manila Times
Ekso Bionics Holdings: Shareholders Board Members Managers and Company Profile | US2826444000 - marketscreener.com
Ekso Bionics Holdings Inc Stock (EKSO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
0.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):